FDA Orders Review of Painkiller Data, Issues Cox-2 Advisory
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
60804
Two years after the withdrawal of the painkiller Vioxx, a dysfunctional Food and Drug Administration still can't adequately track the safety of new drugs and respond quickly to problems, a panel of experts said Friday.
345316
The safety of common painkillers like ibuprofen is to be investigated, European regulators say.
130323
BEIJING, Dec. 24 -- FDA has recommended on Thursday that doctors and users are cautious to use the controversial painkillers -- Pfizer Inc.
367072
U.S. drug regulators on Wednesday will issue a public health advisory about the potential risks of a pain drug made by Cephalon Inc, an agency official said.
397851
The controversy over painkillers known as Cox-2 inhibitors like Vioxx, Celebrex and Bextra and major cardiovascular events has prompted a leading heart specialist to speak out.
201230
Washington - The health risks found in pain-relieving drugs known as COX-2 inhibitors, such as Vioxx, underscore the need for health authorities to test drugs already on the market, a top United States (US) cardiologist has warned.
106310
The US Food and Drug Administration is considering further regulatory measures, including withdrawal from the market, of Pfizer&#39;s arthritis treatment Celebrex.
65811
Patients taking a class of painkilling drugs called Cox-2 inhibitors have been advised to contact their GP to review their treatment.
675666
WASHINGTON -- After months of heightened concerns about the safety and effectiveness of Vioxx and similar best-selling painkillers, and intense criticism of how the Food and Drug Administration has handled them, the agency will launch critical meetings beginning tomorrow on what to do next.
238122
The Food and Drug Administration yesterday called for an evaluation of all prevention studies involving two controversial painkillers - Celebrex and Bextra - to ensure adequate protection for participants who use the pills.
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
369115
The European Commission has ordered a  full-scale probe into the safety of five remaining Cox-2  arthritis drugs, following last month's worldwide withdrawal of  Merck & Co Inc.'s Vioxx.
467561
Dec. 23, 2004 - The Food and Drug Administration today issued a Public Health Advisory summarizing the agency&#39;s recent cautions and recommendations concerning the use of non-steroidal anti-inflammatory drug
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
12623
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will meet early next year to review the safety of a class of drugs, COX-2 inhibitors, used to treat arthritis and pain.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.